Company intelligence / Profile preview

S6 Therapeutics

Ownership: Private
Development stage: Other

Overview

S6 Therapeutics appears to have been a small private drug discovery biotechnology company founded by Stephen Barat. Publicly available references to the company are sparse, but they indicate it focused on drug discovery in cancer, diabetes, and neurodegenerative diseases. No evidence of an active operating website, ongoing clinical programs, financing history, or later-stage development activities was readily identifiable in current public sources. Based on the limited available record, the company seems to have remained an early-stage discovery venture rather than an established clinical-stage biotech.

Therapeutic areas: OncologyEndocrinologyNeurology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on S6 Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on S6 Therapeutics.

Explore the full profile